Esports Team REJECT Renews Rohto Pharmaceutical Partnership Through 2026
The renewal extends a multi-year corporate sponsorship in esports, signaling sustained brand investment in gaming-community marketing through fiscal 2026.
Reporting from 1 sources: GameBusiness.jp.
Esports team REJECT and Rohto Pharmaceutical renewed their partnership contract on June 10, 2026, extending their collaboration from 2023 through fiscal year 2026. The companies will continue promotional measures featuring REJECT players and streamers, along with event-linked projects aimed at the gaming community.
REJECT, the esports team operated by REJECT Inc. and led by CEO Shoya Koyama, announced the contract renewal on June 10. The partnership, first established in 2023, has focused on promotional campaigns using REJECT players and streamers, as well as event-linked projects. Rohto Pharmaceutical said it extended the contract to support REJECT's challenges. Koyama said the team will continue seeking communication methods that feel natural to the gaming community.
Synthesized by Yomimono from the 1 cited source below, including Japanese-language reporting where cited, then editorially reviewed before publishing.
Sources
- GameBusiness.jp eスポーツチーム「REJECT」、ロート製薬とのパートナーシップ契約を更新——2023年から続く協業を2026年度も継続